GlycoMimetics Inc (GLYC) concluded trading on Thursday at a closing price of $0.17, with 3.69 million shares of worth about $0.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.84% during that period and on October 24, 2024 the price saw a loss of about -2.08%. Currently the company’s common shares owned by public are about 64.39M shares, out of which, 59.08M shares are available for trading.
Stock saw a price change of 9.65% in past 5 days and over the past one month there was a price change of 8.97%. Year-to-date (YTD), GLYC shares are showing a performance of -92.64% which decreased to -84.89% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.14 but also hit the highest price of $3.53 during that period. The average intraday trading volume for GlycoMimetics Inc shares is 1.08 million. The stock is currently trading 9.53% above its 20-day simple moving average (SMA20), while that difference is up 4.82% for SMA50 and it goes to -85.90% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GlycoMimetics Inc (NASDAQ: GLYC) currently have 64.39M outstanding shares and institutions hold larger chunk of about 35.62% of that.
The stock has a current market capitalization of $11.21M and its 3Y-monthly beta is at 2.04. It has posted earnings per share of -$0.61 in the same period. It has Quick Ratio of 5.48 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GLYC, volatility over the week remained 12.08% while standing at 8.10% over the month.
Stock’s fiscal year EPS is expected to rise by 12.93% while it is estimated to increase by 82.18% in next year.
Coverage by CapitalOne stated GlycoMimetics Inc (GLYC) stock as an Overweight in their note to investors on December 22, 2023, suggesting a price target of $12 for the stock. On November 12, 2021, Jefferies Upgrade their recommendations, while on November 14, 2019, ROTH Capital Initiated their ratings for the stock with a price target of $12. Stock get a Hold rating from SunTrust on August 05, 2019.
